Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Thoracic 1

Conditions

Neuroblastoma 2Lung Neoplasms 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × beta-Glucans × Clear all
NCT00492167 2022-03-07

Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
45 enrolled
CNS

Neuroblastoma

NCT01829373 2013-04-11

Lung Cancer Vaccine Plus Oral Dietary Supplement

University of Kentucky

Phase 1 Completed
5 enrolled
Thoracic

Lung Neoplasms

NCT00037011 2013-01-18

Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡